Skip Navigation

Cardiovascular Research 2002 56(1):8-14; doi:10.1016/S0008-6363(02)00534-5
© 2002 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by van der Laarse, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van der Laarse, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2002, European Society of Cardiology

Hypothesis: troponin degradation is one of the factors responsible for deterioration of left ventricular function in heart failure

A. van der Laarsea,b,*

aDepartment of Cardiology, C5-P, Leiden University Medical Center, P.O. Box 9600, Leiden, The Netherlands
bThe Interuniversity Cardiology Institute of the Netherlands, Utrecht, The Netherlands

* Tel.: +31-71-526-2020; fax: +31-71-526-6809 a.van_der_laarse{at}LUMC.nl

A hypothesis is presented that explains one of the mechanisms by which a heart starts to fail. The hypothesis is that myocardial function of an overloaded or otherwise stressed heart may become impaired by cellular troponin degradation in vital cardiomyocytes. The troponins (I, T and C) regulate actin–myosin interaction, thereby controlling contraction and relaxation. Troponins have been shown to be targets of activated calpain I. This enzyme, that is activated by elevated intracellular Ca2+ concentrations, such as occurs during ischemia, degrades troponins, leading to impaired interaction between actin and myosin and, thereby, less contractile force. Several reports about troponin degradation in viable myocardium support this hypothesis. Also, results are discussed that demonstrate the presence of immunoreactive troponin fragments in plasma under conditions in which myocardial necrosis can be excluded or is unlikely. The hypothesis implicates that release of troponin and/or troponin degradation products is not specific for necrotic myocardium but may occur from viable myocardium as well. To test this hypothesis, several lines of research are suggested. If the hypothesis is not rejected in the near future, the concept that a positive troponin test reflects even microscopic zones of myocardial necrosis as used by the Joint ESC/ACC Committee for the Redefinition of Myocardial Infarction [The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. Myocardial infarction redefined—A consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. Eur Heart J 2000;21:1502–1513], should be withdrawn.

KEYWORDS Contractile apparatus; Contractile function; Heart failure; Ischemia; Necrosis; Stunning


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Sci SignalHome page
J. Liu, M. C. Liu, and K. K. W. Wang
Calpain in the CNS: From Synaptic Function to Neurotoxicity
Sci. Signal., April 8, 2008; 1(14): re1 - re1.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
N. Hamdani, V. Kooij, S. van Dijk, D. Merkus, W. J. Paulus, C. d. Remedios, D. J. Duncker, G. J.M. Stienen, and J. van der Velden
Sarcomeric dysfunction in heart failure
Cardiovasc Res, March 1, 2008; 77(4): 649 - 658.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
S. Senthil, M. Sridevi, and K. V. Pugalendi
Cardioprotective Effect of Oleanolic Acid on Isoproterenol-Induced Myocardial Ischemia in Rats
Toxicol Pathol, April 1, 2007; 35(3): 418 - 423.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. H. M. Hessel, P. Steendijk, B. den Adel, C. I. Schutte, and A. van der Laarse
Characterization of right ventricular function after monocrotaline-induced pulmonary hypertension in the intact rat
Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2424 - H2430.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
M. Adamcova, M. Sterba, T. Simunek, A. Potacova, O. Popelova, and V. Gersl
Myocardial regulatory proteins and heart failure
Eur J Heart Fail, June 1, 2006; 8(4): 333 - 342.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
S. Kilickap, I. Barista, E. Akgul, K. Aytemir, S. Aksoyek, S. Aksoy, I. Celik, S. Kes, and G. Tekuzman
cTnT can be a useful marker for early detection of anthracycline cardiotoxicity
Ann. Onc., May 1, 2005; 16(5): 798 - 804.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. van der Velden, D. Merkus, B.R. Klarenbeek, A.T. James, N.M. Boontje, D.H.W. Dekkers, G.J.M. Stienen, J.M.J. Lamers, and D.J. Duncker
Alterations in Myofilament Function Contribute to Left Ventricular Dysfunction in Pigs Early After Myocardial Infarction
Circ. Res., November 26, 2004; 95(11): e85 - e95.
[Abstract] [Full Text]


Home page
CirculationHome page
A. Torbicki, M. Kurzyna, P. Kuca, A. Fijalkowska, J. Sikora, M. Florczyk, P. Pruszczyk, J. Burakowski, and L. Wawrzynska
Detectable Serum Cardiac Troponin T as a Marker of Poor Prognosis Among Patients With Chronic Precapillary Pulmonary Hypertension
Circulation, August 19, 2003; 108(7): 844 - 848.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.